H- and K- ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice

Journal of Toxicology and Environmental Health

Volumn 47, Issue 2, 1996, Pages 195-208

  Manjanatha, Mugimane G ^a   Li, Eddie E ^a,b   Fu, Peter P ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; BENZO[A]PYRENE; CARCINOGEN; CHRYSENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; LIVER TUMOR; MALE; MOUSE; MUTATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STRAIN DIFFERENCE;

AMINOBIPHENYL COMPOUNDS; ANIMALS; BASE SEQUENCE; BENZO(A)PYRENE; CHRYSENES; GENES, RAS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTATION;

ANIMALIA;

EID: 0030065903     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/009841096161898     Document Type: Article

References (58)

1. Adams, W. T., and Skopek, T. R. 1987. Statistical test for the comparison of samples from mutational spectra. J. Mol. Biol. 194:391-396.
2. Anderson, B., Hou, S. M., and Lambert, B. 1992a. Mutations causing defective splicing in the human hprt gene. Environ. Mol. Mutagen. 20:89-95.
3. Anderson, B., Falt, S., and Lambert, B. 1992b. Strand specificity for mutations induced by BPDE in the hprt gene in human T-lymphocytes. Mutat. Res. 269:129-140.
4. Anna, C. H., Maronpot, R. R., Pereira, M. A., Foley, J. F., Malarkey, D. E., and Anderson, M. W. 1994. Ras protooncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1mice. Carcinogenesis 15:2255-2261.
5. Balmain, A., and Brown, K. 1988. Oncogene activation in chemical carcinogenesis. Adv. Cancer Res. 51:147-182.
6. Barbacid, M. 1987. Ras genes. Annu. Rev. Biochem. 56:779-827.
7. Beland, F. A., and Kadlubar, F. F. 1985. Formation and persistence of arylamine DNA adducts in vivo. Environ. Health Perspect. 62:19-30.
8. Beland, F. A., and Kadlubar, F. F. 1990. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Handbook of Experimental Pharmacology, Vol. 94/I, Chemical Carcinogenesis and Mutagenesis, eds. C. S. Cooper and P. L. Grover, pp. 267-325. Berlin: Springer-Verlag.
9. Beland, F. A., Beranek, D. T., Dooley, K. L., Heflich, R. H., and Kadlubar, F. F. 1983. Arylamine-DNA adducts in vitro and in vivo—Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect. 49:125-134.
10. Bigger, C. A. H., Sawicki, J. T., Blake, D. M., Raymond, L. G., and Dipple, A. 1983. Products of binding DMBA to DNA in mouse skin. Cancer Res. 43:5647-5651.
11. Bos, J. L. 1988. The ras family and human carcinogenesis. Mutat. Res. 195:255-271.
12. Buchmann, A., Mahr, J., Bauer-Hofmann, R., and Schwarz, M. 1989. Mutations at codon 61of the Haras protooncogene in precancerous liver lesions of the B6C3F, mouse. Mol. Carcinogen. 2:121-125.
13. Buchmann, A., Bauer-Hofmann, R., Mahr, J., Drinkwater, N. R., Luz, A., and Schwarz, M. 1991. Mutation activation of the c-Ha-ras gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA 88:911-915.
14. Cariello, N. F., Piegorsch, W. W., Adams, W. T., and Skopek, T. R. 1994. Computer program for the analysis of mutational spectra: Application to p53 mutations. Carcinogenesis 15:2281-2285.
15. Carothers, A. M., Mucha, J., and Grunberger, D. 1991. DNA strand-specific mutations induced by BcPHDE in the dihydrofolate reductase gene. Proc. Natl. Acad. Sci. USA 88:5749-5753.
16. Cha, R. S., Thilly, W. G., and Zarbl, H. 1994. N-Nitroso N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogene H-ras1gene mutations. Proc. Natl. Acad. Sci. USA 91:3749-3753.
17. Chen, B., Liu, L., Castonguay, A., Maronpot, R. R., Anderson, M. W., and You, M. 1993. Dose-dependent ras mutation spectra in N-nitrosodiethylamine-induced mouse liver tumors and 4-(methyl-nitrosoamino)-1-(3-pyri dyl)-1-butanone-induced mouse lung tumors. Carcinogenesis 14:1603-1608.
18. Chen, R. H., Maher, V. M., and McCormick, J. J. 1990. Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by BPDE in the coding region of the hprt gene. Proc. Natl. Acad. Sci. USA 87:8680-8684.
19. Chen, R. H., Maher, V. M., and McCormick, J. J. 1991. Lack of a cell cycle dependent strand bias for mutations in the hprt gene by BPDE in excision repair-deficient human cells. Cancer Res. 51:2587-2592.
20. Delclos, K. B., Walker, R. P., Dooley, K. L., Fu, P. P., and Kadlubar, F. F. 1987. Carcinogen-DNA adduct formation in the lungs and livers of preweanling CD-1male mice following administration of [H]6-nitrochrysene, [H]6-aminochrysene, and [H]1- 6-dinitropyrene. Cancer Res. 47:6272-6277.
21. Delclos, K. B., El-Bayoumy, K., Hecht, S. S., Walker, R. P., and Kadlubar, F. F. 1988. Metabolism of the carcinogen [H]6-nitrochrysene in the preweanling mouse: Identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite. Carcinogenesis 9:1875-1884.
22. Devanesan, P. D., Ramakrishna, N. V., Padmavathi, N. S., Higginbothams, S., Rogan, B. G., Cavalieri, E. L., Marsch, G. A., Jankowiak, R., and Small, G. J. 1993. Identification and quantitation of DMBA-DNA adducts in mouse skin. Chem. Res. Toxicol. 6(3):364-371.
23. Devereux, T. R., White, C. M., Sills, R. C., Bucher, J. R., Maronpot, R. R., and Anderson, M. W. 1994. Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1mice exposed to oxazepam in the diet. Carcinogenesis 15:1083-1087.
24. Dragani, T. A., Menenti, G., Colombo, B. M., Falvella, F. S., Gariboldi, M., Pierotti, M. A., and Della Porta, G. 1991. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Oncogene 6:333-338.
25. Drinkwater, N. R., Hanigan, M. H., and Kemp, C. J. 1989. Genetic determinants of hepatocarcinogene-sis in the B6C3F1mouse. Toxicol. Lett. 49:255-265.
26. Goodman, D. G., Boorman, G. A., and Strandberg, J. D. 1985. Selection and use of the B6C3F1mouse and F344 rat in long-term bioassays for carcinogenicity. In Handbook of carcinogen testing, eds. H. A. Milman and E. K. Weisburger, pp. 282-325. Park Ridge, N.J.: Noyes Publications.
27. Goodman, J. I., Ward, J. M., Popp, J. A., Klaunig, J. E., and Fox, T. R. 1991. Mouse liver carcinogenesis: Mechanisms and relevance. Fundam. Appl. Toxicol. 17:651-665.
28. Guerrero, I., and Pellicer, A. 1987. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat. Res. 185:293-308.
29. Heflich, R. H. 1991. Chemical mutagens. In Genetic toxicology, eds. A. P. Li and R. H. Heflich, pp. 143-202. Boca Raton, Fla.: CRC Press.
30. Kadlubar, F. F., Beland, F. A., Beranek, D. T., Dooley, K. L., Heflich, R. H., and Evans, F. E. 1982. In Environmental mutagens and carcinogens, eds. T. Sugimura, S. Kondo, and H. Takebe, pp. 385-396. New York: Alan R. Liss.
31. Keohavong, P., and Thilly, W. G. 1992. Mutational spectrometry: A general approach for hot-spot point mutations in selectable genes. Proc. Natl. Acad. Sci. USA 89:4623-4629.
32. Kohler, S. W., Provost, G. S., Fieck, A., Kretz, P. L., Bullock, B., Sorge, J. A., Putman, D., and Short, J. 1991. Spectra of spontaneous and mutagen-induced mutations in the LacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA 88:7958-7962.
33. Lasko, D. D., Harvey, C. S., Malaikal, S. B., Kadlubar, F. F., and Essigman, J. M. 1988. Specificity of mutagenesis by 4-aminobiphenyl. J. Biol. Chem. 263:15429-15435.
34. Li, E. E., Heflich, R. H., and Delclos, K. B. 1993. trans-1,2-Dihydro-1,2-dihydroxy-6-aminochrysene is metabolized to form a major adduct with deoxyguanosine and produces mutations in the hprt gene of CHO cells at G:C basepairs. Carcinogenesis 14:2109-2114.
35. Li, E. E., Heflich, R. H., Bucci, T. J., Manjanatha, M. G., Blaydes, B. S., and Delclos, K. B. 1994. Relationships of DNA adduct formation, K-ras activating mutations and carcinogenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1mice. Carcinogenesis 15:1377-1385.
36. Manam, S., Storer, R. D., Prahalada, S., Leander, K. R., Kraynak, A. R., Ledwith, B. J., van Zwieten, M. J., Bradley, M. O., and Nichols, W. 1992. Activation of the H-, Ki- and N-ras genes in chemically induced liver tumors from CD-1mice. Cancer Res. 52:3347-3352.
37. Mazur, M., and Glickman, B. W. 1988. Sequence specificity of mutations induced by BPDE at the endogenous aprt gene in CHO cells. Somat. Cell Mol. Genet. 14:393-400.
38. Melchior, W. B., Jr., Marques, M. M., and Beland, F. A. 1994. Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis 15:889-899.
39. Neri, A., Knowles, D. M., Greco, A., McCormick, F., and Dalla-Favera, R. 1988. Analysis of ras oncogene mutations in human lymphoid malignancies. Proc. Natl. Acad. Sci. USA 85:9268-9272.
40. Pourzand, C., and Cerutti, P. 1993. Genotypic mutation analysis by RFLP/PCR. Mutat. Res. 288:113-121.
41. Rao, G. N., Birnbaum, L. S., Collins, J. J., Tennant, R. W., and Skow, L. C. 1988. Mouse strains for chemical carcinogenicity studies: Overview of a workshop. Fundam. Appl. Toxicol. 10:385-394.
42. Ramakrishna, N. V., Devanesan, P. D., Rogan, E. G., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. 1992. Mechanism of metabolic activation of the potent carcinogen DMBA. Chem. Res. Toxicol. 5(2):220-226.
43. Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., and Aaronson, S. A. 1986. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F, mouse. Proc. Natl. Acad. Sci. USA 83:33-37.
44. Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., and Anderson, M. W. 1987. Activated oncogenes in B6C3F, mouse liver tumors: Implications for risk assessment. Science 237:1309-1316.
45. Richardson, K. K., Helvering, L. H., Copple, D. M., Rexroat, M. A., Linville, D. W., Engelhardt, J. A., Todd, G. C., and Richardson, F. C. 1992a. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1mouse bioassay studies conducted from 1979 to 1986. Carcinogenesis 13:935-941.
46. Richardson, K. K., Rexroat, M. A., Helvering, L. M., Copple, D. M., and Richardson, F. C. 1992b. Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1mice to DEN. Carcinogenesis 13:1277-1279.
47. Sambrook, J., Fritsch, E. F., and Maniatis, T. 1989. Isolation of high molecular weight DNA from mammalian cells. In Molecular cloning: A laboratory manual, 2nd ed., pp. 9.16-9.19. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
48. Stanley, L. A., Devereux, T. R., Foley, J., Lord, P. G., Maronpot, R. R., Orton, T. C., and Anderson, M. W. 1992. Protooncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis 13:2427-2433.
49. Stanley, L. A., Blackburn, D. R., Devereux, S., Foley, J., Lord, P. G., Maronpot, R. R., Orton, T. C., and Anderson, M. W. 1994. Ras mutations in methylclofenapate-induced B6C3F1and C57BL/10J mouse liver tumors. Carcinogenesis 15:1125-1131.
50. Stowers, S. J., Wiseman, R. W., Ward, J. M., Miller, E. C., Miller, J. A., Anderson, M. W., and Eva, A. 1988. Detection of activated protooncogenes in N-nitrosodiethylamine-induced liver tumors: A comparison between B6C3F, mice and Fischer 344 rats. Carcinogenesis 9:271-276.
51. Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K., and Sekiya, T. 1990. Detection of ras mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5:1037-1043.
52. van Zwieten, M. J., Majka, J. A., Peter, C. P., and Burek, J. D. 1988. The value of historical control data. In Carcinogenecity, eds. H. C. Grice and J. L. Ciminera, pp. 39-51. New York: Springer-Verlag.
53. Wang, Y., Wang, Y., Stoner, G., and You, M. 1993. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3 H/HeJ and (C3HXA/J) F1mice. Cancer Res. 53:1620-1624.
54. Wei, S. J. C., Chang, R. L., Wong, C. Q., Bhachech, N., Cui, X. X., Henning, E., Yagi, H., Sayer, J. M., Jerina, D. M., Preston, B. D., and Conney, A. H. 1991. Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 88:11227-11230.
55. Wei, S. J. C., Chang, R. L., Bhachech, N., Cui, X. X., Merkler, K. A., Wong, C. Q., Henning, E., Yagi, H., Jerina, D. M., and Conney, A. H. 1993. Dose-dependent differences in the profile of mutations induced by BPDE in the coding region of the hprt gene in CHO V-79 cells. Cancer Res. 53:3294-3300.
56. 1mouse. Proc. Natl. Acad. Sci. USA 83:5825-5829.
57. Yang, J. L., Chen, R. H., Maher, V. M., and McCormick, J. J. 1991. Kinds and locations of mutations induced by BPDE in the coding region of the hprt gene in diploid human fibroblasts. Carcinogenesis 12:71-75.
58. Zhan, D. J., Heflich, R. H., and Fu, P. P. 1994. Molecular characterization of mutations in the hprt gene of CHO cells induced by benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide and two nitrated derivatives. Environ. Mol. Mutagen. 23:76 (abstr.).